{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:50:24Z","timestamp":1762188624297,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CLRPG3D0046","CORPG3G0271","CORPG3J0031","NMRPG3H6271","NMRPG3H6272"],"award-info":[{"award-number":["CLRPG3D0046","CORPG3G0271","CORPG3J0031","NMRPG3H6271","NMRPG3H6272"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["107-2314-B-182A-159-MY2"],"award-info":[{"award-number":["107-2314-B-182A-159-MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.atherosclerosis.2021.03.022","type":"journal-article","created":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T11:09:52Z","timestamp":1616670592000},"page":"76-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Bleeding associated with co-administration of clopidogrel and ACEi in patients undergoing PCI and DAPT"],"prefix":"10.1016","volume":"324","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9918-4369","authenticated-orcid":false,"given":"Victor Chien-Chia","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3224-7238","authenticated-orcid":false,"given":"Yu-Tung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Tzu","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Fu","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Shien","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1994-4664","authenticated-orcid":false,"given":"Chi-Ching","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-Hung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib1","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.amjcard.2019.09.003","article-title":"Prescription patterns of clopidogrel, prasugrel, and ticagrelor after percutaneous coronary intervention with stent implantation (from the NCDR PINNACLE registry)","volume":"124","author":"Khalid","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib2","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/dmd.109.029132","article-title":"Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite","volume":"38","author":"Kazui","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/FPC.0b013e3283385420","article-title":"Clopidogrel pathway","volume":"20","author":"Sangkuhl","year":"2010","journal-title":"Pharmacogenetics Genom."},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib5","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/cpt.1507","article-title":"Clopidogrel drug interactions and serious bleeding: generating real-world evidence via automated high-throughput pharmacoepidemiologic screening","volume":"106","author":"Leonard","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib8","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2010.11.024","article-title":"Clopidogrel-drug interactions","volume":"57","author":"Bates","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1503\/cmaj.070186","article-title":"Drug-drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding","volume":"177","author":"Delaney","year":"2007","journal-title":"CMAJ."},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/clpt.2014.183","article-title":"Clopidogrel bioactivation and risk of bleeding in patients cotreated with angiotensin-converting enzyme inhibitors after myocardial infarction: a proof-of-concept study","volume":"96","author":"Kristensen","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib11","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib12","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1161\/CIR.0000000000000133","article-title":"Society for cardiovascular angiography and interventions and the society of thoracic surgeons","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib13","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.jacc.2009.10.015","volume":"54","author":"Kushner","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib14","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jacc.2016.05.011","volume":"68","author":"Yancy","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib15","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ehj.2004.06.003","article-title":"Task Force on ACE-inhibitors of the European Society of Cardiology. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology","volume":"25","author":"L\u00f3pez-Send\u00f3n","year":"2004","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib16","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1001\/jama.2017.13883","article-title":"Association between use of non-vitamin K oral anticoagulants with and without concurrent medications and risk of major bleeding in Nonvalvular Atrial Fibrillation","volume":"318","author":"Chang","year":"2017","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib17","article-title":"Assessing major bleeding risk in atrial fibrillation patients concurrently taking non-vitamin K antagonist oral anticoagulants and antiepileptic drugs","author":"Wang","year":"2019","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib18","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.bcp.2008.12.017","article-title":"Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril","volume":"77","author":"Zhu","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1124\/dmd.113.053512","article-title":"In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors. Drug Metab","volume":"42","author":"Thomsen","year":"2014","journal-title":"Dispos"},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/jpm8010008","article-title":"Pharmacogenomic impact of CYP2C19 variation on clopidogrel therapy in precision cardiovascular medicine","volume":"8","author":"Brown","year":"2018","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/JCMA.0000000000000101","article-title":"Investigating CYP2C19 loss-of-function allele statuses and their association with stroke of different etiologies in a Taiwanese population","volume":"82","author":"Lee","year":"2019","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib22","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/JCMA.0000000000000168","article-title":"CYP2C19 loss-of-function alleles: a common but overlooked problem associated with clopidogrel resistance","volume":"82","author":"Chi","year":"2019","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib23","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.12659\/MSM.892475","article-title":"Analysis of the CYP2C19 genetic polymorphism in han and Uyghur patients with cardiovascular and cerebrovascular diseases in the kashi area of xinjiang","volume":"20","author":"Li","year":"2014","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib24","first-page":"1911","article-title":"Angiotensin-converting enzyme inhibitors' influence on antiplatelet therapy of clopidogrel in","volume":"62","author":"Yang","year":"2016","journal-title":"ACS. Clin Lab ."},{"key":"10.1016\/j.atherosclerosis.2021.03.022_bib25","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/eurheartj\/ehr204","article-title":"Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology","volume":"32","author":"Steg","year":"2011","journal-title":"Eur. Heart J."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502100143X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502100143X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:25:25Z","timestamp":1762187125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191502100143X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":23,"alternative-id":["S002191502100143X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.03.022","relation":{},"ISSN":["0021-9150"],"issn-type":[{"type":"print","value":"0021-9150"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bleeding associated with co-administration of clopidogrel and ACEi in patients undergoing PCI and DAPT","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}